To the Editor The study by Dr Xing and colleagues1 explored the association between the BRAF V600E mutation and mortality in patients with papillary thyroid cancer (PTC) in a large retrospective cohort of 1849 patients from 13 centers worldwide. The authors concluded that the BRAF mutation was significantly associated with cancer-related mortality.
Ciarrocchi A, Cavuto S, Piana S. BRAF V600E Mutation and Papillary Thyroid Cancer. JAMA. 2013;310(5):534. doi:10.1001/jama.2013.8589